New Delhi/IBNS: No quarantine will be required for the fully vaccinated Indians travelling to the UK from October 11, the British High Commissioner to India, Alex Ellis said Thursday.
New Delhi/IBNS: A number of India's private hospitals have cancelled their orders for Russia's Sputnik V vaccine as they struggled to sell the Covid-19 shot amid a surge in free doses administered by the government.
New Delhi/IBNS: Prime Minister Narendra Modi Monday praised the CoWIN days after the United Kingdom had raised questions over the web portal, which is used for online registration and certification of anti-COVID-19 vaccine in the South Asian country.
New Delhi/IBNS: India has dismissed the "vaccination certification issues" cited by the British authorities for not exempting Indians vaccinated with two doses of Covishield from mandatory quarantine on their arrival in the UK.
New Delhi/IBNS: India's warning has prompted the United Kingdom to approve Serum Institute of India (SII)'s anti-COVID-19 vaccine, Covishield, but questions have been raised over the CoWIN certificate, in what could further escalate the bilateral tension.
Imphal/IBNS: Three persons have been arrested for allegedly trying to smuggle Covid vaccines and other medicines to Myanmar, Manipur Police said.
New Delhi/IBNS: Several government-run vaccination centres in Delhi will be closed on Tuesday as the national capital has exhausted its Covishield COVID-19 vaccine stock, Deputy Chief Minister Manish Sisodia said on Monday.
New Delhi/IBNS: In a big diplomatic win for India, seven European Union (EU) nations along with Switzerland and Iceland have cleared Serum Institute of India (SII)'s anti-COVID-19 vaccine Covishield amid row over travel pass, media reports said.
New Delhi/IBNS: In a strong-worded communication, India has asked the European Union that either Covishield and Covaxin must be notified in its digital COVID certificate or people from the EU will face mandatory quarantine upon arrival in the Asian country.
Pune/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Monday said he hopes to resolve the issues which Covishield-vaccinated Indians, who are planning to travel to Europe, are facing.
New Delhi/IBNS: India has raised the concerns of students vaccinated with indigenously developed Covaxin and planning a return to US educational institutions during a meeting between foreign secretary Harsh Shringla and US chargé d’ affaires Daniel Smith, said a Hindustan Times report.
Srinagar/IBNS: At least 488 Covishield doses were administered during the drive, organised by the University Health Centre in collaboration with the Department of Social and Preventive Medicine Government Medical College Srinagar, Block Hazratbal.
New Delhi/IBNS: The Centre on Tuesday rejected claims that it could allow mixing of vaccines and reduce the Covishield vaccine schedule to a single shot, after unofficial sources informed media about the key pointers of such a plan, eliciting resistance from the medical community.
Pune/IBNS: The Serum Institute of India (SII) has said it will be able to manufacture and supply 90 to 100 million doses of Covishield in June, media reports said.
Pune/IBNS: Adar Poonawalla, CEO of Serum Institute of India (SII), the manufacturer of Covishield, on Tuesday said that his company has "never exported vaccines at the cost of the people of India".